OTCMKTS:KNBWY

Kirin Q2 2026 Earnings Results & Report

Kirin logo
$19.61 -0.22 (-1.11%)
As of 01:44 PM Eastern

Kirin beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 7, 2026. The company reported EPS of $0.58 versus the $0.4209 consensus estimate, while revenue of $4.08 billion topped the $3.87 billion estimate by $205.35 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Kirin EPS Results

Actual EPS
$0.58
Consensus EPS
$0.4209
Beat/Miss
Beat by +$0.1591
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 7 quarters

Kirin Revenue Results

Actual Revenue
$4.08 billion
Expected Revenue
$3.87 billion
Beat/Miss
Beat by +$205.35 million
YoY Revenue Growth
N/A

Conference Call Resources

Kirin Q2 2026 Earnings FAQ

Kirin (OTCMKTS:KNBWY) reported earnings of $0.58 per share for Q2 2026, beating the consensus estimate of $0.4209. The report was announced on Friday, August 7, 2026.

Kirin reported revenue of $4.08 billion for Q2 2026, against a consensus estimate of $3.87 billion.

Kirin Earnings Headlines

Under 3 cents a night
Bill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night. With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies. No re-bills and nothing to install. At $7, the only question is whether you get around to it.tc pixel
Kirin (KNBWY) Set to Announce Earnings on Tuesday
See More Kirin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kirin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kirin and other key companies, straight to your email.

About Kirin

Kirin (OTCMKTS:KNBWY) Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets.

The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.

Kirin is headquartered in Tokyo and serves customers across Japan and overseas, including markets in Asia-Pacific and other regions through its operating companies and businesses. Its portfolio spans consumer beverages as well as health-related products and medicines.

View Kirin Profile